Epigraph hemagglutinin vaccine induces broad cross-reactive immunity against swine H3 influenza virus

Brianna L. Bullard, Brigette N. Corder, Jennifer DeBeauchamp, Adam Rubrum, Bette Korber, Richard J. Webby, Eric A. Weaver

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Influenza A virus infection in swine impacts the agricultural industry in addition to its zoonotic potential. Here, we utilize epigraph, a computational algorithm, to design a universal swine H3 influenza vaccine. The epigraph hemagglutinin proteins are delivered using an Adenovirus type 5 vector and are compared to a wild type hemagglutinin and the commercial inactivated vaccine, FluSure. In mice, epigraph vaccination leads to significant cross-reactive antibody and T-cell responses against a diverse panel of swH3 isolates. Epigraph vaccination also reduces weight loss and lung viral titers in mice after challenge with three divergent swH3 viruses. Vaccination studies in swine, the target species for this vaccine, show stronger levels of cross-reactive antibodies and T-cell responses after immunization with the epigraph vaccine compared to the wild type and FluSure vaccines. In both murine and swine models, epigraph vaccination shows superior cross-reactive immunity that should be further investigated as a universal swH3 vaccine.

Original languageEnglish (US)
Article number1203
JournalNature communications
Issue number1
StatePublished - Dec 1 2021

ASJC Scopus subject areas

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)


Dive into the research topics of 'Epigraph hemagglutinin vaccine induces broad cross-reactive immunity against swine H3 influenza virus'. Together they form a unique fingerprint.

Cite this